SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1993 |
Sector | Life Science |
Employees | 38 |
Revenue | 26M USD (2018) |
ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. ArQule's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to human cancers. ArQule was formed in 1993 and is based in Burlington, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 1 of 2 |
Sector (Life Science) | 1 of 2 |
Type (Add-on Acquisition) | 1 of 2 |
State (California) | 1 of 1 |
Country (United States) | 1 of 2 |
Year (2001) | 1 of 1 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2003-07-17 |
Cyclis Pharmaceuticals
Norwood, Massachusetts, United States Cyclis is discovering and developing small-molecule cancer drugs based on a novel technology designed to selectively kill cancer cells and preserve normal cells by restoring and activating cellular checkpoints known to be defective in cancers. |
Buy | $25M |